title: The role of disease burden measures in future estimates of endemic waterborne disease.
abstract: The 1996 Safe Drinking Water Act amendments require the US Environmental Protection Agency and the Centers for Disease Control and Prevention to develop a national estimate of the occurrence of waterborne infectious disease that is attributable to public drinking water systems in the United States. Much of the information for developing the national estimate will be derived from epidemiologic data, and the primary outcome of this effort will be an estimate of the number of cases of gastrointestinal illness. While quantifying the number of these cases provides some measure of waterborne disease impact, the usefulness of this measure may be limited because the full spectrum of societal impact also involves consideration of the additional effects of these diseases such as hospitalization costs and lost productivity. If decision-makers wish to compare the impact of waterborne infectious diseases to the impact of some other public health concern (e.g. to aid in resource allocation decisions), then a comparison of case numbers may prove inadequate. Case numbers alone do not provide sufficient information about the severity of different illnesses. Society may value the avoidance of a few cases of severely debilitating illness more than it values the avoidance of many cases of mild illness. In order to compare disparate public health concerns, "burden of disease" measures that incorporate indicators of disease severity, costs, or societal values may prove essential for some types of decisions. We describe epidemiologic measures of severity, quality adjusted life years (QALYs), disability adjusted life years (DALYs), willingness-to-pay, and cost-of-illness methods commonly used for burden of disease estimates, and discuss how some of these summary measures of burden might be used for waterborne disease estimates.
authors.affiliation: US Environmental Protection Agency, 26 W. Martin Luther King Dr. (MS-A110), Cincinnati, OH 45268, USA. rice.glenn@epa.gov
authors.forename: Glenn
authors.initials: G
authors.lastname: Rice
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Heberling
authors.forename: Mary
authors.initials: M
authors.lastname: Rothermich
authors.forename: J Michael
authors.initials: JM
authors.lastname: Wright
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Murphy
authors.forename: Michael F
authors.initials: MF
authors.lastname: Craun
authors.forename: Gunther F
authors.initials: GF
authors.lastname: Craun
mesh_terms: D002908:Chronic Disease / Q000191:economics; D003141:Communicable Diseases / Q000453:epidemiology; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D004812:Epidemiologic Methods; D005767:Gastrointestinal Diseases / Q000191:economics / Q000453:epidemiology*; D006801:Humans; D008017:Life Expectancy; D011634:Public Health; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D014481:United States / Q000453:epidemiology; D014871:Water Microbiology / Q000592:standards*